Document is current
Any future updates will be listed below
-
Authors
Kumar, Senthil T. https://orcid.org/0000-0002-4322-3963
Nazarov, Sergey
Porta, SÃlvia
Maharjan, Niran
Cendrowska, Urszula
Kabani, Malek
Finamore, Francesco
Xu, Yan
Lee, Virginia M.-Y. https://orcid.org/0000-0003-3536-6902
Lashuel, Hilal A. https://orcid.org/0000-0001-7682-8320
- License Information
-
More Information
Article History
Received: 24 May 2022
Accepted: 18 April 2023
First Online: 29 May 2023
Competing interests
: H.A.L. is the founder and chief scientific officer of ND BioSciences, Epalinges, Switzerland, a company that develops diagnostics and treatments for NDs based on platforms that reproduce the complexity and diversity of proteins implicated in NDs and their pathologies. H.A.L. has received funding from the industry to support research on neurodegenerative diseases, including from Merck Serono, AC Immune, UCB Idorsia and Abbvie. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The remaining authors declare no competing interests.
